NCT04245098 (AMICAR) is a NA clinical trial of Carpal tunnel syndrome surgery in Amyloidosis, sponsored by Corporacion Parc Tauli.

Who is sponsoring NCT04245098?

NCT04245098 is sponsored by Corporacion Parc Tauli.

What drugs are being tested in NCT04245098?

Interventions in NCT04245098: Carpal tunnel syndrome surgery.

What condition does NCT04245098 study?

NCT04245098 studies Amyloidosis, Carpal Tunnel Syndrome.

Is NCT04245098 still recruiting?

NCT04245098 is currently status unknown. Last updated 28 January 2020.

Last reviewed 2020-01-28 · How we verify

NCT04245098: AMICAR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Carpal Tunnel Syndrome and Amyloidosis

Status unknown NA Last updated 28 January 2020

What this trial tests

NA trial testing Carpal tunnel syndrome surgery in Amyloidosis in 100 participants. Status unknown.

Timeline

8 January 2020

Primary endpoint
8 January 2022

8 January 2023

Quick facts

Lead sponsor	Corporacion Parc Tauli
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	100
Start date	8 January 2020
Primary completion	8 January 2022
Estimated completion	8 January 2023
Sites	1 location across Spain

Drugs / interventions tested

Carpal tunnel syndrome surgery

Conditions studied

Amyloidosis — all drugs for Amyloidosis →
Carpal Tunnel Syndrome — all drugs for Carpal Tunnel Syndrome →

Sponsor

Corporacion Parc Tauli — full company profile →

Who can join

Eligibility, any sex, with Amyloidosis or Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Carpal tunnel syndrome has been suggested to be an early sign of amyloidosi. The investigators will evaluate tissue samples obtained from patients undergoing carpal tunnel release surgery for amyloid.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Early Diagnosis of Amyloidosis and Cardiac Involvement through Carpal Tunnel Surgery and Predictive Factors.
Navarro-Saez MDC, Feijoo-Massó C, Berenguer Sánchez A, Parra Parente T, et al · · 2024 · cited 5× · PMID 39124595 · DOI 10.3390/jcm13154328

Verify or expand the search:

Other recruiting trials for Amyloidosis

Currently open trials in the same condition.

NCT07285044 — The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr · Phase 2 · recruiting
NCT06974877 — Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure · Phase 1 · recruiting
NCT07081646 — A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloido · Phase 1, PHASE2 · recruiting
NCT07232459 — [18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis · recruiting
NCT06573723 — Institutional Registry of Rare Diseases · recruiting

Other Corporacion Parc Tauli trials

Trials by the same sponsor.

NCT07331805 — Conservative Management in Primary Spontaneous Pneumothorax: a Multicenter Randomized Non-inferiority Study · NA · not yet recruiting
NCT06873360 — Medical Device for Oxaliplatin-Induced Neuropathy in Gastrointestinal Cancer Patients · completed
NCT06900335 — Functional Connectome in Prader-Willi Syndrome: Neuroimaging and AI to Assess Therapeutic Impact · completed
NCT06511700 — Implementation of the Intravitreal Injection Administered by Nurses · enrolling by invitation
NCT07298720 — Assessing Fluid-responsiveness Using Non-invasive Hybrid Diffuse Optics on Peripheral Muscle · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04245098 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Corporacion Parc Tauli
Last refreshed: 28 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04245098.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing